News | December 24, 2023
Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Total transaction value of the divestment is Rs. 3,660 million
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Subscribe To Our Newsletter & Stay Updated
